References
- Muenz L R. Comparing survival distributions: A review for nonstatisticians. I. Cancer Invest 1983; 1: 455–466
- Muenz L R. Comparing survival distributions: A review for nonstatisticians. II. Cancer Invest 1983; 1: 537–545
- Cancer Clinical Trials—Methods and Practice, M E Buyse, M J Staquet, R J Sylvester. Oxford University Press, Oxford 1984
- Peto J. The calculation and interpretation of survival curves. Cancer Clinical Trials—Methods and Practice, M E Buyse, M J Staquet, R J Sylvester. Oxford University Press, Oxford 1984
- Breslow N. Comparison of survival curves. Cancer Clinical Trials—Methods and Practice, M E Buyse, M J Staquet, R J Sylvester. Oxford University Press, Oxford 1984; 381–406
- Byar D P. Identification of prognostic factors. Cancer Clinical Trials—Methods and Practice, M E Buyse, M J Staquet, R J Sylvester. Oxford University Press, Oxford 1984; 423–443
- Simon R. Use of regression models: Statistical aspects. Cancer Clinical Trials—Methods and Practice, M E Buyse, M J Staquet, R J Sylvester. Oxford University Press, Oxford 1984; 444–466
- Stablein D M, Carter W H, Novak J W. Analysis of survival data with nonproportional hazard functions. Control Clin Trials 1981; 2: 149–159
- Cox D R. Regression models and life tables (with discussion). J R Statist Soc 1972; B34: 187–220
- Langlands A O, Pocock S J, Kerr G, Gore S M. Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J 1979; 2: 1247–1251
- Gore S M, Langlands A O, Pocock S J, Kerr G R. Natural history of breast cancer. Adjuvant Therapies of Cancer, G Mathe, G Bonnadonna, S Salmon. Springer, Berlin, Heidelberg, New York 1982, (Recent Results in Cancer Research, Vol. 80)
- Pocock S J, Gore S M, Kerr G R. Long-term survival analysis: The curability of breast cancer. Statis Med 1982; 1: 93–104
- Fleming T R, O'Fallon J R, O'Brien P C, Harrington D P. Modified Kolmogorov-Smirnov test procedures with applications to arbitrarily censored data. Biometrics 1980; 36: 607–625
- Fleming T R, Green S J, Harrington D P. Considerations for monitoring and evaluating treatment effects in clinical trials. Control Clin Trials 1984; 5: 55–66
- Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 1980; 67: 145–153
- Andersen P K. Testing goodness-of-fit of Cox's regression model. Biometrics 1983; 38: 67–77
- Schumacher M, Vaeth M. On a goodness-of-fit test for the proportional hazards model. EDP Biol Med 1984; 15: 19–23
- Schumacher M. Two-sample tests of Cramer-von Mises-and Kolomogorov-Smirnov-type for randomly censored data. Int Statist Rev 1984; 52: 263–281
- Gill R, Schumacher M. A Simple test of the proportional hazards assumption. Biometrika 1987; 74: 289–300
- Andersen P K. Comparing survival distributions via hazard ratio estimates. Scand J Statist 1983; 10: 77–85
- Prentice R L. Linear rank tests with right censored data. Biometrika 1978; 63: 291–298
- Kay R. Goodness-of-fit methods for the proportional hazards regression model: A review. Rev Epidem 1984; 32: 185–198
- Clayton D G, Kaldor J M. Diagnostic plots for departures from proportional hazards in cohort study data. J Chron Dis 1987; 40(Suppl. 2)125S–132S
- Anderson J A, Senthilselvan A. A two-step regression model for hazard functions. Appl Statist 1982; 31: 44–51
- Schumacher M, Olschewski M, Schmoor C. The impact of heterogeneity on the comparison of survival times. Stat Med 1987; 6: 773–784
- Byar D P. Assessing apparent treatment-covariate interactions in randomized clinical trials. Stat Med 1985; 4: 255–263
- Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41: 361–372
- Kay R. Treatment effects in competing-risks analysis of prostate cancer data. Biometrics 1986; 42: 203–211